巴贝虫病

Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366:2397-2407.

• 摘要

Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-1134. [Erratum in: Clin Infect Dis. 2007;45:941.]

• 全文
• 摘要

Sanchez E, Vannier E, Wormser GP, et al. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016;315:1767-1777.

• 摘要

1.  Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366:2397-2407.

• 摘要

2.  Hunfeld KP, Hildebrandt A, Gray JS. Babesiosis: recent insights into an ancient disease. Int J Parasitol. 2008;38:1219-1237.

• 摘要

3.  Häselbarth K, Tenter AM, Brade V, et al. First case of human babesiosis in Germany - clinical presentation and molecular characterisation of the pathogen. Int J Med Microbiol. 2007;297:197-204.

• 摘要

4.  Conrad PA, Kjemtrup AM, Carreno RA, et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol. 2006;36:779-789.

• 摘要

5.  Hatcher JC, Greenberg PD, Antique J, et al. Severe babesiosis in Long Island: review of 34 cases and their complications. Clin Infect Dis. 2001;32:1117-1125.

• 全文
• 摘要

6.  Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-1134. [Erratum in: Clin Infect Dis. 2007;45:941.]

• 全文
• 摘要

7.  Froberg MK, Dannen D, Bernier N, et al. Spontaneous splenic rupture during acute parasitemia of Babesia microti. Ann Clin Lab Sci. 2008;38:390-392.

• 全文
• 摘要

8.  Gelfand JA, Vannier E. Babesia species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious disease. 6th ed. Philadelphia, PA: Elsevier; 2005:3209-3215.

9.  Centers for Disease Control and Prevention (CDC). Babesiosis surveillance - 18 states, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:505-509.

• 全文
• 摘要

10.  Krause PJ, McKay K, Gadbaw J, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg. 2003;68:431-436.

• 摘要

11.  Gerber MA, Shapiro ED, Krause PJ, et al. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis. 1994;170:231-234.

• 摘要

12.  Gubernot DM, Lucey CT, Lee KC, et al. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis. 2009;48:25-30.

• 摘要

13.  Krause PJ, Spielman A, Telford SR 3rd, et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 1998;339:160-165.

• 全文
• 摘要

14.  Herwaldt BL, Linden JV, Bosserman E, et al. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155:509-519.

• 摘要

15.  Joseph JT, Purtill K, Wong SJ, et al. Vertical transmission of Babesia microti, United States. Emerg Infect Dis. 2012;18:1318-1321.

• 全文
• 摘要

16.  Weiss LM. Babesiosis in humans: a treatment review. Expert Opin Pharmacother. 2002;3:1109-1115.

• 摘要

17.  Murase T, Maede Y. Increased erythrophagocytic activity of macrophages in dogs with Babesia gibsoni infection. Nippon Juigaku Zasshi. 1990;52:321-327.

• 摘要

18.  Ruebush MJ, Hanson WL. Thymus dependence of resistance to infection with Babesia microti of human origin in mice. Am J Trop Med Hyg. 1980;29:507-515.

• 摘要

19.  Igarashi I, Suzuki R, Waki D, et al. Roles of CD4(+) T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infect Immun. 1999;67:4143-4148.

• 全文
• 摘要

20.  Benach JL, Habicht GS, Holbrook TW, et al. Glucan as an adjuvant for a murine Babesia microti immunization trial. Infect Immun. 1982;35:947-951.

• 全文
• 摘要

21.  Aguilar-Delfin I, Wettstein PJ, Persing DH. Resistance to acute babesiosis is associated with interleukin-12- and gamma interferon-mediated responses and requires macrophages and natural killer cells. Infect Immun. 2003;71:2002-2008.

• 全文
• 摘要

22.  Krause PJ, Gewurz BE, Hill D, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46:370-376.

• 全文
• 摘要

23.  Taiwo B, Lee C, Venkat D, et al. Can tumor necrosis factor alpha blockade predispose to severe babesiosis? Arthritis Rheum. 2007;57:179-181.

• 摘要

24.  Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2013;57:e22-e121.

• 全文
• 摘要

25.  Wang G, Wormser GP, Zhuge J, et al. Utilization of a real-time PCR assay for diagnosis of Babesia microti infection in clinical practice. Ticks Tick Borne Dis. 2015;6:376-382.

• 摘要

26.  Wang G, Villafuerte P, Zhuge J, et al. Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans. Diagn Microbiol Infect Dis. 2015;82:109-113.

• 摘要

27.  Sanchez E, Vannier E, Wormser GP, et al. Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: a review. JAMA. 2016;315:1767-1777.

• 摘要

28.  Wormser GP, Prasad A, Neuhaus E, et al. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. Clin Infect Dis. 2010;50:381-386.

• 全文
• 摘要

29.  Raoult D, Soulayrol L, Toga B, et al. Babesiosis, pentamidine, and cotrimoxazole. Ann Intern Med. 1987;107:944.

• 摘要

30.  Shaio MF, Yang KD. Response of babesiosis to a combined regimen of quinine and azithromycin. Trans R Soc Trop Med Hyg. 1997;91:214-215.

• 摘要

31.  Shih CM, Wang CC. Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans. Am J Trop Med Hyg. 1998;59:509-512.

• 全文
• 摘要

32.  Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. 1996;22:809-812.

• 摘要

33.  Vyas JM, Telford SR, Robbins GK. Treatment of refractory Babesia microti infection with atovaquone-proguanil in an HIV-infected patient: case report. Clin Infect Dis. 2007;45:1588-1590.

• 全文
• 摘要

34.  Leiby P. Transfusion-associated babesiosis: shouldn’t we be ticked off? Ann Intern Med. 2011;155:556-557.

• 摘要